Recently Viewed
Clear All
Bidding Date
03-Jul-2024 to
05-Jul-2024
Issue Size
₹1952.03 Cr
Price Band
₹960 to ₹1008
Allotment date
08-Jul-2024
Listing date
10-Jul-2024
Lot size
14
No. of shares
1,93,65,347
Fresh issue/OFS
₹800 Cr/₹1152.03 Cr
Emcure Pharmaceuticals Ltd is an Indian pharmaceutical company, renowned for developing, manufacturing, and globally marketing a wide range of pharmaceutical products. Established in 1981, the company has built a reputation as a research and development (R&D) driven entity. Their business model is centered around a differentiated product portfolio that includes orals, injectables, and biotherapeutics, enabling them to cater to a broad range of therapeutic areas. Their operations span over 70 countries, with significant market presence in India, Europe, and Canada. Their operations are segmented into chronic and acute therapeutic areas, with a significant emphasis on the former due to its higher growth potential. Chronic therapeutic areas, including sub-chronic, accounted for 46.22% of their total Domestic Sales for FY24.
Read our in-depth analysis of the Emcure Pharmaceuticals Ltd IPO Here 
Category
Status
QIBs
195.8x
NIIs
48.3x
Retail
7.2x
Others
--
Total
67.8x
| Name | Price Band (Rs) | Bidding Date |
|---|---|---|
| Speciality Medicines | 117 - 124 | 20-Mar-2026 to 24-Mar-2026 |
| Central Mine Planning & Design Institute | 163 - 172 | 20-Mar-2026 to 24-Mar-2026 |
| Novus Loyalty | 139 - 146 | 17-Mar-2026 to 20-Mar-2026 |
| Highness Microelectronics | 114 - 120 | 24-Mar-2026 to 27-Mar-2026 |
The issue size of Emcure Pharmaceuticals is ₹1,952.03 Cr.
Emcure Pharmaceuticals falls into Pharmaceuticals industry.
The Emcure Pharmaceuticals IPO will be listed on both NSE and BSE.
The open and close dates for the Emcure Pharmaceuticals are 03-Jul-2024 & 05-Jul-2024.
The price band for the Emcure Pharmaceuticals ipo is ₹960 to ₹1008
The listing date of Emcure Pharmaceuticals IPO is 10-Jul-2024.
The purpose of this IPO is to raise fresh capital as well as enable the existing shareholders to sell their stake.
Emcure Pharmaceuticals total subscription ratio is 67.8X.
Key financial of the Emcure Pharmaceuticals are:
| Emcure Pharmaceuticals | FY-24 | FY-23 | FY-22 |
|---|---|---|---|
| Revenue (₹ Cr) | 6658.25 | 5985.81 | 5855.39 |
| EBIT (₹ Cr) | 917.32 | 921.06 | 1085.05 |
| Proft after Tax (₹ Cr) | 527.58 | 561.85 | 702.56 |
| Debt (₹ Cr) | 2072.49 | 2181.61 | 2077.27 |
| Net Worth (₹ Cr) | 3121.77 | 2649.66 | 2114.14 |
| RoE (%) | 16.9 | 21.2 | 33.23 |
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
